Tranylcypromine [MAOI] in attention deficit hyperactivity disorder in children
Egyptian Journal of Psychiatry [The]. 1992; 15 (1): 66-70
em Inglês
| IMEMR
| ID: emr-23560
ABSTRACT
Tranylcypromine [MAOI] was administered to twenty seven children [mean age 7.4 years +/- 3.2] with DSM-III-R Attention Deficit Hyperactivity Disorder [ADHD]. Comparison of pre-and post-medication behavioral assessments using the Conners Abbreviated Hyperactivity Rating Scale showed a statistically significant difference [P< 0.001] which suggest that tranylcypromine could be an effective antihyperactivity drug
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Tranilcipromina
/
Transtornos do Comportamento Infantil
/
Psiquiatria Infantil
/
Transtornos Mentais
/
Antidepressivos
Idioma:
Inglês
Revista:
Egypt. J. Psychiatry
Ano de publicação:
1992
Similares
MEDLINE
...
LILACS
LIS